日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Bone metastases are associated with worse prognosis in patients affected by metastatic colorectal cancer treated with doublet or triplet chemotherapy plus bevacizumab: a subanalysis of the TRIBE and TRIBE2 trials

TRIBE 和 TRIBE2 试验的亚组分析显示,接受双药或三药化疗联合贝伐单抗治疗的转移性结直肠癌患者,骨转移与预后不良相关:

Dell'Aquila, E; Rossini, D; Fulgenzi, C A M; Passardi, A; Tamburini, E; Vetere, G; Carullo, M; Citarella, F; Antoniotti, C; Zaniboni, A; Pietrantonio, F; Spagnoletti, A; Marmorino, F; Borelli, B; Allegrini, G; Lonardi, S; Nappo, F; Masi, G; Cremolini, C; Santini, D

A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients.

转移性结直肠癌患者节拍式伊立替康的药代动力学和药效学研究

Allegrini G, Falcone A, Fioravanti A, Barletta M T, Orlandi P, Loupakis F, Cerri E, Masi G, Di Paolo A, Kerbel R S, Danesi R, Del Tacca M, Bocci G